Leading bank tips AstraZeneca as 2026’s standout UK pharma, with GSK left trailing
JPMorgan has put AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) at the top of its UK healthcare picks for 2026, arguing that the company…
92,830$
0,26%
Echtzeit-Aktienkurs Astrazeneca PLC (Spons. ADRs)
Bid:
Ask:
Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie
ANALYSE-FLASH: JPMorgan hebt Novartis auf Overweight - Ziel 125 Franken
NEW YORK (dpa-AFX Broker) - Die US-Bank JPMorgan hat das Kursziel für Novartis von 95 auf 125 Franken angehoben…
AstraZeneca or Merck: Which Oncology Giant Has the Edge?
AZN and MRK boast major oncology strengths and expanding pipelines amid shifting market dynamics in this pharma matchup.…
Why Medicare price negotiations matter for Novo Nordisk, AstraZeneca, and other European pharma companies
Pharma companies are facing pricing pressure from several directions, including from the U.S. Medicare negotiations…
Why AstraZeneca Stock Bumped Higher Today
The company is wasting little time figuring out the particulars of a sweeping capital investment program.…
AstraZenecas $2B manufacturing investment in Maryland to create jobs
AstraZeneca is investing $2 billion in manufacturing in Maryland that will support 2,600 jobs, state and company officials announced Friday.…
AstraZeneca to invest $2 billion expanding Maryland manufacturing sites By Investing.com
AstraZeneca to invest $2 billion expanding Maryland manufacturing sites…
AstraZeneca to invest $2 billion as part of US manufacturing push
AstraZeneca said on Friday it will invest $2 billion to expand its manufacturing footprint in Maryland as part of its…
Chutes & Ladders— Former FDA official to lead policy at Hims & Hers; ATA CEO to retire in December
Welcome to this weeks Chutes & Ladders, our roundup of hirings, firings and retirings throughout the industry. Please submit the…
Why Astrazeneca (AZN) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why…
FTSE 100 hits record high as job market data weakens pound; AstraZeneca shines By Reuters
FTSE 100 hits record high as job market data weakens pound; AstraZeneca shines…
Lisata (LSTA) Q3 2025 Earnings Call Transcript
Image source: The Motley Fool.DATEThursday, Nov. 6, 2025 at 4:30 p.m. ETCALL PARTICIPANTSPresident and Chief Executive Officer — Dr. David…
AZN Q3 Earnings Top Estimates, Sales Rise As Most Key Drugs Outperform
AstraZeneca posts strong Q3 results. Core earnings and revenues beat estimates as key drugs like Tagrisso, Imfinzi and Farxiga fuel…
AstraZeneca climbs to new high after US deal reassurance
AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) posted what analysts called a very solid set of third-quarter results, where guidance was maintained and the…
AstraZeneca climbs to net all-time high after US deal reassurance
AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) posted what analysts called a very solid set of third-quarter results, but the shares barely moved in…
Astrazeneca: Starkes Quartal dank Krebsarzneien und gute Aussichten für 2026
CAMBRIDGE (dpa-AFX) - Der Pharmakonzern Astrazeneca hat ein weiteres überraschend starkes Quartal hinter sich. In den drei Monaten bis…
AstraZeneca beats forecasts in Q3, reaffirms full-year guidance By Investing.com
AstraZeneca beats forecasts in Q3, reaffirms full-year guidance…
AstraZeneca grows faster than expected but maintains guidance
AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) posted a confident set of third-quarter results, not only beating revenue and core earnings forecasts, but also...…
FTSE 100 Live: Blue-chips slide as Smith & Nephew disappoints, Bank of England holds
FTSE 100 falls 20 points to 9,757 Bank of England decision due at midday AstraZeneca beats forecasts but shares little-moved Towering…
AstraZeneca beats third-quarter revenue and profit expectations
AstraZeneca beat third-quarter earnings expectations on Thursday, helped by strong sales of key cancer, heart and kidney disease drugs, prompting…